Clinical and Translational Medicine (Oct 2021)

The oral KIF11 inhibitor 4SC‐205 exhibits antitumor activity and potentiates standard and targeted therapies in primary and metastatic neuroblastoma models

  • Marc Masanas,
  • Nuria Masiá,
  • Leticia Suárez‐Cabrera,
  • Mireia Olivan,
  • Aroa Soriano,
  • Blanca Majem,
  • Laura Devis‐Jauregui,
  • Rebeca Burgos‐Panadero,
  • Carlos Jiménez,
  • Pau Rodriguez‐Sodupe,
  • Ariadna Boloix,
  • Ignasi Toledano,
  • Gabriela Guillén,
  • Alexandra Navarro,
  • David Llobet‐Navas,
  • Alberto Villanueva,
  • Josep Sánchez de Toledo,
  • Josep Roma,
  • Rosa Noguera,
  • Lucas Moreno,
  • Rolf Krauss,
  • Soledad Gallego,
  • Anna Santamaria,
  • Miguel F. Segura

DOI
https://doi.org/10.1002/ctm2.533
Journal volume & issue
Vol. 11, no. 10
pp. n/a – n/a

Abstract

Read online

No abstracts available.